Alerts will be sent to your verified email
Verify Email
REKVINA LAB.
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Rekvina Laboratories Ltd is committed to provide quality medication at affordable prices to the patients with a view to help bring down the healthcare costs.
Rekvina Labs major competitors are Kobo Biotech, Zyden Gentec, Hemo Organic, Hind Bio Science, Ganga Pharma., Adline Chem Lab, MPS Pharmaa.
Market Cap of Rekvina Labs is ₹5 Crs.
While the median market cap of its peers are ₹6 Crs.
Rekvina Labs seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | |||||||||||||||||||
| Investor Presentation | |||||||||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
